These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 9925733)
1. Structure-immunosuppressive activity relationships of new analogues of 15-deoxyspergualin. 1. Structural modifications of the hydroxyglycine moiety. Lebreton L; Annat J; Derrepas P; Dutartre P; Renaut P J Med Chem; 1999 Jan; 42(2):277-90. PubMed ID: 9925733 [TBL] [Abstract][Full Text] [Related]
2. Structure-immunosuppressive activity relationships of new analogues of 15-deoxyspergualin. 2. Structural modifications of the spermidine moiety. Lebreton L; Jost E; Carboni B; Annat J; Vaultier M; Dutartre P; Renaut P J Med Chem; 1999 Nov; 42(23):4749-63. PubMed ID: 10579839 [TBL] [Abstract][Full Text] [Related]
3. Effect of deoxyspergualin on graft-versus-host disease and graft- versus-leukemia in mice. Weiss L; Reich S; Slavin S Bone Marrow Transplant; 1996 May; 17(5):789-92. PubMed ID: 8733699 [TBL] [Abstract][Full Text] [Related]
4. 15-Deoxyspergualin controls cyclosporin- and steroid-resistant intestinal acute graft-versus-host disease after allogeneic bone marrow transplantation. Kasai M; Higa T; Naohara T; Masauzi N; Watanabe M; Matsuura A; Ohizumi H; Tanaka J; Morii K; Kiyama Y Bone Marrow Transplant; 1994 Aug; 14(2):315-7. PubMed ID: 7994248 [TBL] [Abstract][Full Text] [Related]
5. Deoxyspergualin--a different and intriguing immunosuppressant. Tufveson G; Gannedahl G Transplant Proc; 1994 Oct; 26(5):3029-39. PubMed ID: 7940954 [No Abstract] [Full Text] [Related]
6. Reduced levels of Hsp70 result in a therapeutic effect of 15-deoxyspergualin on acute graft-versus-host disease in (DA x LEW)F1 rats. Goral J; Mathews HL; Nadler SG; Clancy J Immunobiology; 2000 Sep; 202(3):254-66. PubMed ID: 11045661 [TBL] [Abstract][Full Text] [Related]
7. Possible mechanism in rat with surviving heart allograft after short course of 15-deoxyspergualin treatment. Jiang H; Takahara S; Kyo M; Takano Y; Kokado Y; Ishibashi M; Sonoda T J Clin Lab Immunol; 1990 Jul; 32(3):131-6. PubMed ID: 1966949 [TBL] [Abstract][Full Text] [Related]
8. Effects of cyclosporine and 15-deoxyspergualin on coronary arteriosclerosis after heart transplantation in the rat. Nagamine S; Ohmi M; Tabayashi K; Iguchi A; Mohri H J Heart Lung Transplant; 1994; 13(5):895-8. PubMed ID: 7803433 [TBL] [Abstract][Full Text] [Related]
9. 15-Deoxyspergualin, an immunosuppressive agent, used in organ transplantation showed suppressive effects on malarial parasites. Midorikawa Y; Haque QM Chemotherapy; 1997; 43(1):31-5. PubMed ID: 8996739 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of spergualin analogues. I. Nishizawa R; Takei Y; Yoshida M; Tomiyoshi T; Saino T; Nishikawa K; Nemoto K; Takahashi K; Fujii A; Nakamura T J Antibiot (Tokyo); 1988 Nov; 41(11):1629-43. PubMed ID: 3242505 [TBL] [Abstract][Full Text] [Related]
11. Elucidating the mechanism of action of the immunosuppressant 15-deoxyspergualin. Nadler SG; Eversole AC; Tepper MA; Cleaveland JS Ther Drug Monit; 1995 Dec; 17(6):700-3. PubMed ID: 8588244 [TBL] [Abstract][Full Text] [Related]
12. 15-Deoxyspergualin: a novel immunosuppressive drug with clinical potential. Thomas FT; Tepper MA; Thomas JM; Haisch CE Ann N Y Acad Sci; 1993 Jun; 685():175-92. PubMed ID: 8363221 [TBL] [Abstract][Full Text] [Related]
13. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine. Ochiai T; Nakajima K; Sakamoto K; Nagata M; Gunji Y; Asano T; Isono K; Sakamaki T; Hamaguchi K Transplant Proc; 1989 Feb; 21(1 Pt 1):829-32. PubMed ID: 2468228 [No Abstract] [Full Text] [Related]
14. Effect of 15-deoxyspergualin on rejection detected by 31P nuclear magnetic resonance spectroscopy and in vivo mechanisms of action in rat heart transplantation. Suzuki S; Kanashiro M; Watanabe H; Sakakibara I; Amemiya H Transplant Proc; 1989 Feb; 21(1 Pt 1):1094-5. PubMed ID: 2523115 [No Abstract] [Full Text] [Related]
15. Deoxyspergualin is a unique immunosuppressive agent with selective utility in inducing tolerance to pancreas islet xenografts. Thomas F; Pittman K; Ljung T; Cekada E Transplant Proc; 1995 Feb; 27(1):417-9. PubMed ID: 7879045 [TBL] [Abstract][Full Text] [Related]
16. Inhibition by deoxyspergualin of allo-reactive cytotoxic activity in mouse graft-versus-host disease. Nemoto K; Hayashi M; Abe F; Takita T; Takeuchi T Transplant Proc; 1989 Feb; 21(1 Pt 3):3028-30. PubMed ID: 2650418 [No Abstract] [Full Text] [Related]
17. Identification of poly(rC) binding protein 2 (PCBP2) as a target protein of immunosuppressive agent 15-deoxyspergualin. Murahashi M; Simizu S; Morioka M; Umezawa K Biochem Biophys Res Commun; 2016 Aug; 476(4):445-449. PubMed ID: 27261432 [TBL] [Abstract][Full Text] [Related]
18. Autoimmune destruction of islet grafts in the NOD mouse is resistant to 15-deoxyspergualin but sensitive to anti-CD4 antibody. Stegall MD; Loberman Z; Ostrowska A; Coulombe M; Gill RG J Surg Res; 1996 Aug; 64(2):156-60. PubMed ID: 8812627 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of graft-versus-host disease and inhibition with deoxyspergualin on small bowel transplantation in rats. Tanaka S; Okada H; Uda K; Fujioka M; Makabe M; Orita T; Orita K Transplant Proc; 1992 Jun; 24(3):1161-3. PubMed ID: 1604569 [No Abstract] [Full Text] [Related]
20. DNA nick end labeling of rat renal allografts treated with 15-deoxyspergualin (DSG). Chikaraishi T; Ishikura H; Seki T; Koyanagi T; Yoshiki T Transplant Proc; 1995 Feb; 27(1):557-8. PubMed ID: 7879097 [No Abstract] [Full Text] [Related] [Next] [New Search]